Pharmaceutical Analysis & Statistics in North America Countries, October 2014 (p10)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

You might be interested in: Therapeutics, Drug, Cancer, more »

271-320 of about 5 100 reports

Purchase Reports From Reputable Market Research Publishers

Canagliflozin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Canagliflozin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Nilotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Nilotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, United States, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Perampanel  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Perampanel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Vandetanib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vandetanib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Vitamins & Minerals in Mexico (2014) - Market Sizes

Vitamins & Minerals in Mexico (2014) - Market Sizes

  • $ 599
  • Industry report
  • October 2014
  • by Mintel

Vitamins & Minerals in Mexico by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers single/dual, multi-vitamins and minerals. It excludes ...

  • Industries : Vitamin and Supplement
  • Countries : Mexico
OTC Medications in Mexico (2014) - Market Sizes

OTC Medications in Mexico (2014) - Market Sizes

  • $ 599
  • Industry report
  • October 2014
  • by Mintel

OTC Medications in Mexico by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological ...

  • Industries : Over-the-counter Drug
  • Countries : Mexico
Orphan Drug Market Access: Payer Insights on the Present and Future

Orphan Drug Market Access: Payer Insights on the Present and Future

  • $ 531
  • Industry report
  • October 2014
  • by Firstword Pharma

Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current ...

  • Industries : Drug and Medication
  • Countries : United States, France, Europe, United Kingdom, Spain, Italy, Germany
Chemical and Pharmaceutical Plants Construction in Mexico to 2018: Market Databook

Chemical and Pharmaceutical Plants Construction in Mexico to 2018: Market Databook

  • $ 500
  • Industry report
  • October 2014
  • by Timetric

Synopsis Timetric's 'Chemical and Pharmaceutical Plants Construction in Mexico to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Mexico
Chemical & Pharmaceutical Plant Construction in Canada to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in Canada to 2018: Market Databook

  • $ 500
  • Industry report
  • October 2014
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Canada to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Canada
North America Hernia Repair Procedures Outlook to 2020

North America Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • July 2014
  • by Global Data

North America Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "North America Hernia Repair Procedures Outlook to 2020", provides key market data on the North America Hernia Repai ...

  • Industries : Pathology
  • Countries : United States, Mexico, Canada, North America
Teva Pharmaceuticals USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Teva Pharmaceuticals USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, ...

  • Industries : Pathology
  • Countries : China, World, United States, India, Asia
Adamis Pharmaceuticals Corporation (Symbol:ADMP) SWOT Analysis, Strategy, Revenues and Profits

Adamis Pharmaceuticals Corporation (Symbol:ADMP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : United States
Aegerion Pharmaceuticals, Inc. (Symbol:AEGR) SWOT Analysis, Strategy, Revenues and Profits

Aegerion Pharmaceuticals, Inc. (Symbol:AEGR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : United States
Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
AGA Medical Holdings, Inc. (Symbol:AGAM) SWOT Analysis, Strategy, Revenues and Profits

AGA Medical Holdings, Inc. (Symbol:AGAM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Alliqua, Inc. (ALQA) - Financial and Strategic SWOT Analysis Review

Alliqua, Inc. (ALQA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Alliqua, Inc. (Alliqua) is a provider of wound care solutions. The company conducts businesses that include advanced wound care, transdermal drug delivery, and contract manufacturing. Its advanced ...

  • Industries : Drug Delivery Technology
  • Countries : United States
Allon Therapeutics Inc. (Symbol:NPC) SWOT Analysis, Strategy, Revenues and Profits

Allon Therapeutics Inc. (Symbol:NPC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Canada
Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United States
Ampio Pharmaceuticals, Inc. (Symbol:AMPE) SWOT Analysis, Strategy, Revenues and Profits

Ampio Pharmaceuticals, Inc. (Symbol:AMPE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Aoxing Pharmaceutical Company, Inc (Symbol:AXN) SWOT Analysis, Strategy, Revenues and Profits

Aoxing Pharmaceutical Company, Inc (Symbol:AXN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : United States
Applied Visual Sciences, Inc. (Symbol:APVS) SWOT Analysis, Strategy, Revenues and Profits

Applied Visual Sciences, Inc. (Symbol:APVS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Arrhythmia Research Technology, Inc. (Symbol:HRT) SWOT Analysis, Strategy, Revenues and Profits

Arrhythmia Research Technology, Inc. (Symbol:HRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Arrowhead Research Corporation (Symbol:ARWR) SWOT Analysis, Strategy, Revenues and Profits

Arrowhead Research Corporation (Symbol:ARWR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Atritech, Inc. SWOT Analysis, Strategy, Revenues and Profits

Atritech, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Autism Speaks, Inc. SWOT Analysis, Strategy, Revenues and Profits

Autism Speaks, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States

82 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Icon Group

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.